Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,784 | -18,518 | -10,199 | -53,342 | -46,087 |
| Depreciation Amortization | 102 | 91 | 89 | 145 | 101 |
| Accounts receivable | -8,906 | -5,468 | -3,132 | -9,811 | -8,303 |
| Accounts payable and accrued liabilities | 2,327 | 893 | 302 | -667 | 1,544 |
| Other Working Capital | 6,328 | 4,614 | 394 | -10,013 | -3,391 |
| Other Operating Activity | 11,456 | 7,717 | 4,327 | 16,431 | 11,063 |
| Operating Cash Flow | $-10,477 | $-10,671 | $-8,219 | $-57,257 | $-45,073 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,736 | 9,736 | 11,523 | -16,866 | -25,228 |
| Investing Cash Flow | $16,736 | $9,736 | $11,523 | $-16,866 | $-25,228 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 25,000 | 20,000 |
| Common Stock Issued | 597 | 561 | N/A | 58,779 | 58,255 |
| Other Financing Activity | 0 | 0 | 0 | -875 | -875 |
| Financing Cash Flow | $597 | $561 | $N/A | $82,904 | $77,380 |
| Beginning Cash Position | 70,542 | 70,542 | 70,542 | 61,761 | 61,761 |
| End Cash Position | 77,398 | 70,168 | 73,846 | 70,542 | 68,840 |
| Net Cash Flow | $6,856 | $-374 | $3,304 | $8,781 | $7,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,477 | -10,671 | -8,219 | -57,257 | -45,073 |
| Free Cash Flow | -10,477 | -10,671 | -8,219 | -57,257 | -45,073 |